Financhill
Sell
34

SAGE Quote, Financials, Valuation and Earnings

Last price:
$5.63
Seasonality move :
0.25%
Day range:
$4.95 - $5.62
52-week range:
$4.62 - $28.26
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.19x
P/B ratio:
0.62x
Volume:
4.3M
Avg. volume:
1.1M
1-year change:
-73.13%
Market cap:
$343.2M
Revenue:
$86.5M
EPS (TTM):
-$5.57
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $6.9M $1.1B $6.3M $7.7M $86.5M
Revenue Growth (YoY) -92.39% 16123.06% -99.43% 21.85% 1024.84%
 
Cost of Revenues $400K $565K $553K $813K $2.2M
Gross Profit $6.5M $1.1B $5.8M $6.9M $84.3M
Gross Profit Margin 94.18% 99.95% 91.23% 89.42% 97.5%
 
R&D Expenses $368.8M $292.7M $283.2M $326.2M $356.2M
Selling, General & Admin $345.8M $197M $183.5M $227.7M $274.5M
Other Inc / (Exp) $82K -$27.5M $134K $15K -$33.8M
Operating Expenses $714.6M $489.7M $466.7M $553.9M $630.8M
Operating Income -$708.1M $624M -$460.9M -$547M -$546.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$680.2M $606.1M -$457.9M -$532.8M -$541.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$680.2M $606.1M -$457.9M -$532.8M -$541.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$680.2M $606.1M -$457.9M -$532.8M -$541.5M
 
Basic EPS (Cont. Ops) -$13.38 $11.66 -$7.80 -$8.98 -$9.05
Diluted EPS (Cont. Ops) -$13.38 $11.43 -$7.80 -$8.98 -$9.05
Weighted Average Basic Share $50.8M $52M $58.7M $59.3M $59.8M
Weighted Average Diluted Share $50.8M $53M $58.7M $59.3M $59.8M
 
EBITDA -$705.8M $626.6M -$456.7M -$545.9M -$545.1M
EBIT -$708.1M $624M -$460.9M -$547M -$546.5M
 
Revenue (Reported) $6.9M $1.1B $6.3M $7.7M $86.5M
Operating Income (Reported) -$708.1M $624M -$460.9M -$547M -$546.5M
Operating Income (Adjusted) -$708.1M $624M -$460.9M -$547M -$546.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.6M $1.4M $1.7M $2.7M $11.9M
Revenue Growth (YoY) -54.09% -12.14% 20.76% 56.18% 337.08%
 
Cost of Revenues $149K $131K $184K $905K $5.3M
Gross Profit $1.5M $1.3M $1.6M $1.8M $6.6M
Gross Profit Margin 90.91% 90.9% 89.42% 66.68% 55.54%
 
R&D Expenses $74.1M $83.5M $81.6M $101.9M $54.6M
Selling, General & Admin $35.1M $48.7M $61.5M $78.1M $53.2M
Other Inc / (Exp) $605K $31K $30K -$33.7M $9K
Operating Expenses $109.2M $132.2M $143M $180.1M $107.8M
Operating Income -$107.7M -$130.9M -$141.5M -$178.3M -$101.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$105.7M -$130.2M -$137.3M -$201.6M -$93.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$105.7M -$130.2M -$137.3M -$201.6M -$93.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$105.7M -$130.2M -$137.3M -$201.6M -$93.6M
 
Basic EPS (Cont. Ops) -$2.03 -$2.21 -$2.31 -$3.37 -$1.53
Diluted EPS (Cont. Ops) -$2.03 -$2.21 -$2.31 -$3.37 -$1.53
Weighted Average Basic Share $52M $58.8M $59.4M $59.9M $61.1M
Weighted Average Diluted Share $52M $58.8M $59.4M $59.9M $61.1M
 
EBITDA -$107M -$130.5M -$141.2M -$177.9M -$100.9M
EBIT -$107.7M -$130.9M -$141.5M -$178.3M -$101.2M
 
Revenue (Reported) $1.6M $1.4M $1.7M $2.7M $11.9M
Operating Income (Reported) -$107.7M -$130.9M -$141.5M -$178.3M -$101.2M
Operating Income (Adjusted) -$107.7M -$130.9M -$141.5M -$178.3M -$101.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $7M $1.1B $6.5M $11.3M $106.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $648K $602K $757K $1.5M $8.8M
Gross Profit $6.3M $1.1B $5.7M $9.9M $97.6M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $302.3M $289.4M $312.3M $381.2M $253.2M
Selling, General & Admin $228.6M $185.4M $215.1M $286.7M $216.9M
Other Inc / (Exp) -$27.6M $325K $75K -$33.9M $126K
Operating Expenses $530.8M $474.8M $524.3M $667.9M $470.1M
Operating Income -$524.5M $638.4M -$518.6M -$658.1M -$372.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$537.5M $641.7M -$510.4M -$655.9M -$337.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$537.5M $641.7M -$510.4M -$655.9M -$337.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$537.5M $641.7M -$510.4M -$655.9M -$337.6M
 
Basic EPS (Cont. Ops) -$10.35 $13.03 -$8.63 -$10.98 -$5.57
Diluted EPS (Cont. Ops) -$10.35 $12.51 -$8.63 -$10.98 -$5.57
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$521.9M $642.9M -$517.4M -$656.8M -$371.2M
EBIT -$524.5M $638.4M -$518.6M -$658.1M -$372.5M
 
Revenue (Reported) $7M $1.1B $6.5M $11.3M $106.4M
Operating Income (Reported) -$524.5M $638.4M -$518.6M -$658.1M -$372.5M
Operating Income (Adjusted) -$524.5M $638.4M -$518.6M -$658.1M -$372.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5M $4.7M $4.8M $8.5M $28.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $429K $466K $670K $1.3M $8M
Gross Profit $4.6M $4.2M $4.2M $7.1M $20.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $211M $207.7M $236.9M $291.9M $188.9M
Selling, General & Admin $143.5M $131.9M $163.5M $219.4M $161.8M
Other Inc / (Exp) -$27.7M $110K $51K -$33.9M $12K
Operating Expenses $354.5M $339.6M $397.3M $511.3M $350.7M
Operating Income -$349.9M -$335.4M -$393.1M -$504.2M -$330.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$368.8M -$333.2M -$385.7M -$508.8M -$304.9M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$368.8M -$333.2M -$385.6M -$508.8M -$304.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$368.8M -$333.2M -$385.6M -$508.8M -$304.9M
 
Basic EPS (Cont. Ops) -$7.10 -$5.68 -$6.51 -$8.51 -$5.03
Diluted EPS (Cont. Ops) -$7.10 -$5.68 -$6.51 -$8.51 -$5.03
Weighted Average Basic Share $155.8M $175.8M $177.7M $179.4M $181.8M
Weighted Average Diluted Share $155.8M $175.8M $177.7M $179.4M $181.8M
 
EBITDA -$347.9M -$331.6M -$392.3M -$503.2M -$329.3M
EBIT -$349.9M -$335.4M -$393.1M -$504.2M -$330.2M
 
Revenue (Reported) $5M $4.7M $4.8M $8.5M $28.4M
Operating Income (Reported) -$349.9M -$335.4M -$393.1M -$504.2M -$330.2M
Operating Income (Adjusted) -$349.9M -$335.4M -$393.1M -$504.2M -$330.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $126.7M $1.7B $294.2M $162.7M $71M
Short Term Investments $881.7M $438.5M $1.4B $1.1B $682.2M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $26.7M $22.8M -- -- --
Other Current Assets -- -- $39.8M $50.8M $31.8M
Total Current Assets $1B $2.1B $1.8B $1.3B $869.4M
 
Property Plant And Equipment $42.9M $31.8M $19.1M $13.4M $6.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $6.2M $5.1M $5.5M $6M $6.5M
Total Assets $1.1B $2.2B $1.8B $1.4B $882.3M
 
Accounts Payable $15.3M $3.7M $10.5M $19M $10.3M
Accrued Expenses $64.6M $40.1M $48.7M $43.3M $45.9M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $10.2M $8.7M $7.5M $7.6M $5.2M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $112.1M $67.2M $85.2M $99.3M $82.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $139.5M $86.9M $96.3M $103.9M $82.7M
 
Common Stock $5K $6K $6K $6K $6K
Other Common Equity Adj $1.3M $415K -$2.7M -$10.2M -$814K
Common Equity $944.7M $2.1B $1.7B $1.3B $799.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $944.7M $2.1B $1.7B $1.3B $799.5M
 
Total Liabilities and Equity $1.1B $2.2B $1.8B $1.4B $882.3M
Cash and Short Terms $1B $2.1B $1.7B $1.3B $753.2M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $184.3M $422.2M $199.8M $148.7M $99.6M
Short Term Investments $484.3M $1.4B $1.2B $727.3M $469.5M
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $30.3M $34.3M $53M -- --
Other Current Assets -- -- -- $34.7M $19.6M
Total Current Assets $698.9M $1.9B $1.5B $933.3M $605M
 
Property Plant And Equipment $34M $20.3M $14.8M $8.5M $12.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $5.8M $5.1M $6.2M $7.9M $5.2M
Total Assets $738.6M $1.9B $1.5B $949.7M $622.4M
 
Accounts Payable $4.3M $4.7M $7.1M $11.1M $7.1M
Accrued Expenses $37.6M $55.4M $64.8M $100.8M $36.2M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $8.6M $7.4M $7.6M $7M $83K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $59.7M $78.9M $99.7M $133M $60.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $81M $91.5M $106M $133M $70.6M
 
Common Stock $5K $6K $6K $6K $6K
Other Common Equity Adj $946K -$306K -$14.9M -$3.7M $901K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $657.6M $1.8B $1.4B $816.7M $551.8M
 
Total Liabilities and Equity $738.6M $1.9B $1.5B $949.7M $622.4M
Cash and Short Terms $668.5M $1.8B $1.4B $876.1M $569.2M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$680.2M $606.1M -$457.9M -$532.8M -$541.5M
Depreciation & Amoritzation $2.3M $2.6M $4.2M $1.1M $1.4M
Stock-Based Compensation $153.2M $96M $104.6M $61.6M $73.4M
Change in Accounts Receivable -- -- -$18.5M $4.8M -$69.3M
Change in Inventories -- -- -- -- --
Cash From Operations -$528.7M $664.3M -$378.2M -$460M -$540.6M
 
Capital Expenditures $5.8M $345K $372K $937K $553K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$143.2M $442.7M -$1B $325.4M $442.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$2.5M -- -$1.4M -$43K -$903K
Cash From Financing $607.6M $426.8M $13.3M $3.1M $6M
 
Beginning Cash (CF) $193.3M $129.1M $1.7B $295.5M $164M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$64.2M $1.5B -$1.4B -$131.5M -$91.6M
Ending Cash (CF) $129.1M $1.7B $295.5M $164M $72.3M
 
Levered Free Cash Flow -$534.5M $663.9M -$378.6M -$461M -$541.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$105.7M -$130.2M -$137.3M -$201.6M -$93.6M
Depreciation & Amoritzation $650K $374K $278K $330K $255K
Stock-Based Compensation $20.1M $34.3M $13.2M $28.7M $14.2M
Change in Accounts Receivable -- $24.3M $5.3M -$7.4M -$4.9M
Change in Inventories -- -- -- -- --
Cash From Operations -$91M -$68.8M -$118.9M -$135.9M -$82.4M
 
Capital Expenditures -$1K -- $364K $328K --
Cash Acquisitions -- -- -- -- --
Cash From Investing $13.5M -$25M $111M $160.4M $81.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$15K -$4K -$399K
Cash From Financing $3.5M $1.8M $1.2M $2.8M $1M
 
Beginning Cash (CF) $260.6M $515.4M $207.8M $122.7M $102.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$74M -$92M -$6.7M $27.3M -$274K
Ending Cash (CF) $186.6M $423.4M $201.1M $150M $102.5M
 
Levered Free Cash Flow -$91M -$68.8M -$119.2M -$136.2M -$82.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$537.5M $641.7M -$510.4M -$655.9M -$337.6M
Depreciation & Amoritzation $2.6M $4.5M $1.2M $1.3M $1.3M
Stock-Based Compensation $105.9M $104.7M $67M $75.7M $58M
Change in Accounts Receivable -- -$24.2M $5.7M -$4.1M $7.6M
Change in Inventories -- -- -- -- --
Cash From Operations -$463.4M $730.3M -$430.6M -$548M -$320.2M
 
Capital Expenditures $718K -- $655K $947K -$112K
Cash Acquisitions -- -- -- -- --
Cash From Investing $379.2M -$926.7M $205.4M $490.6M $262.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$645K -$781K
Cash From Financing $9.3M $433.2M $2.9M $6.3M $10.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$74.9M $236.8M -$222.3M -$51.1M -$47.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$464.1M $730.3M -$431.3M -$548.9M -$320.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$368.8M -$333.2M -$385.6M -$508.8M -$304.9M
Depreciation & Amoritzation $2M $3.8M $832K $984K $902K
Stock-Based Compensation $75.3M $84M $46.4M $60.4M $45.1M
Change in Accounts Receivable -- -$24.2M $58K -$8.9M $68.1M
Change in Inventories -- -- -- -- --
Cash From Operations -$346.7M -$280.7M -$333.1M -$421.1M -$200.6M
 
Capital Expenditures $345K -- $655K $665K --
Cash Acquisitions -- -- -- -- --
Cash From Investing $397.2M -$972.2M $235.7M $400.9M $220.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -$796K -$39K -$641K -$519K
Cash From Financing $7.1M $13.5M $3M $6.3M $10.7M
 
Beginning Cash (CF) $591.5M $3.1B $683.2M $494.5M $350.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $57.6M -$1.2B -$94.4M -$13.9M $30.1M
Ending Cash (CF) $649M $1.8B $588.8M $480.6M $380.7M
 
Levered Free Cash Flow -$347M -$280.7M -$333.8M -$421.7M -$200.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is down 1.41% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 8.28% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock